Lexington Medical, Inc.
 | |
| Private | |
| ISIN | 🆔 |
| Industry | Medical devices |
| Founded 📆 | 2013 |
| Founder 👔 | |
Area served 🗺️ | |
Key people | Leon Amariglio (CEO) |
| Members | |
Number of employees | |
| 🌐 Website | Official website |
| 📇 Address | |
| 📞 telephone | |
Lexington Medical is a privately held U.S. medical device company headquartered in Massachusetts that designs and manufactures surgical stapler devices intended for minimally invasive surgery.
Company History
Lexington Medical, Inc. was founded in 2013[1] by Leon Amariglio. In 2017, it received U.S. FDA 510(k) clearance for the AEON Endoscopic Stapler.[2] In 2021, Bariatric News reported on AEON’s 10,000-surgery milestone and highlighted data from a comparative clinical trial showing AEON produced a lower mean bleeding score (2.1 vs. 2.6) and zero cases of profuse bleeding as compared to a leading competitor.[3] In 2024, GlobalData reported sustained revenue growth from 2017-2023, supporting Lexington Medical's market presence in surgical stapling.[4] In 2024, the company received FDA clearance for the AEON Endoscopic Powered Stapler[5] as reported by Modern Healthcare which highlighted it among notable device clearances of the year.[6]
Clinical Use
AEON surgical staplers are intended to staple and cut tissue for resection, transection, and creation of anastomosis. Clinical performance has been evaluated in peer-reviewed studies examining intra and post-operative outcomes.[7][8][9] A first-in-man trial evaluating the AEON Powered Stapling System was presented in the British Journal of Surgery in 2024. The study assessed device safety, firing mechanism performance, and initial clinical outcomes, contributing to the body of evidence supporting AEON’s surgical utility.[10]
In March 2025, the journal *Innovations in Hepatopancreatobiliary Surgery* published a detailed review of the AEON endovascular stapler alongside the LOTUS‑Bowa liver blade. The review highlighted AEON’s innovative design and reported outcomes, including a reduction in postoperative pancreatic fistula from 65% to 20% during distal pancreatectomy, along with enhanced staple-line hemostasis in comparison to Medtronic’s EndoGIA device.[11]
References
- ↑ "Lexington Medical, Inc. - Corporation Summary". Massachusetts Secretary of the Commonwealth. Retrieved 2025-07-02.
- ↑ "Premarket Notification 510(k) Summary - K171589". U.S. Food and Drug Administration. Retrieved 2025-07-02.
- ↑ "Lexington's AEON Endostapler reaches 10,000 procedure milestone". Bariatric News. April 21, 2021. Retrieved 2025-07-22.
- ↑ "Lexington Medical Inc, United States Revenue". MedicalDevice-Network.com (GlobalData). June 16, 2021. Retrieved July 16, 2025.
- ↑ "Premarket Notification 510(k) Summary - K234039". U.S. Food and Drug Administration. Retrieved 2025-07-02.
- ↑ Kacik, Alex (June 28, 2024). "FDA clears 8 devices, including AI-driven surgical tools". Modern Healthcare. Retrieved July 17, 2025.
- ↑ Raftopoulos, Yannis; Rajkumar, Shruthi; Davidson, Elana; Papasavas, Pavlos (2022). "Prospective Randomized Comparison of Linear Endostaplers During Laparoscopic Sleeve Gastrectomy". Obesity Surgery. 32 (10): 3472–3480. doi:10.1007/s11695-022-06240-4. PMID 35974292 Check
|pmid=value (help). - ↑ Sheen, Aali J.; Bandyopadhyay, Samik; Baltatzis, Minas; Deshpande, Rahul; Jamdar, Saurabh; de Liguori Carino, Nicola (2023). "Preliminary experience in laparoscopic distal pancreatectomy using the AEON endovascular stapler". Frontiers in Oncology. 13: 1146646. doi:10.3389/fonc.2023.1146646. PMC 10130406 Check
|pmc=value (help). PMID 37124511 Check|pmid=value (help). - ↑ Redmann, James G.; Lavin, Thomas E.; French, Matthew S. (2020). "Improving Hemostasis in Sleeve Gastrectomy With Alternative Stapler". JSLS. 24 (4): e2020.00073. doi:10.4293/JSLS.2020.00073. PMC 7791089 Check
|pmc=value (help). PMID 33447003 Check|pmid=value (help). - ↑ "First-in-man experience using the AEON Powered Stapling System". British Journal of Surgery. 112 (Supplement_5): znaf036.042. 2024. Retrieved 2025-07-21.
- ↑ Sheen, Aali J.; Barrie, Jenifer; Stathakis, Panagiotis; Jamdar, Saurabh (March 2025). "Innovations in Hepatopancreatobiliary Surgery: A Review of LOTUS‑Bowa Liver Blade and AEON Endovascular Stapler". Innovations in Hepatopancreatobiliary Surgery. Retrieved 2025-07-21.
This article "Lexington Medical, Inc." is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Lexington Medical, Inc.. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
